Company intelligence / Profile preview

PLAIO

Ownership: Private
Employees: ~17
Development stage: Commercial

Overview

PLAIO offers an AI-powered visual planning and decision support platform specifically designed for pharmaceutical manufacturing and supply chain management. The system integrates with existing ERP systems to optimize sales and operations planning using advanced mathematical modeling and artificial intelligence. It enables scenario analysis, real-time data integration, and natural language queries to streamline complex pharma workflows. The company has raised significant venture funding (€6.7 million as of mid 2024) and reports strong customer adoption among mid-sized pharmaceutical manufacturers. No clinical results are relevant as the company does not develop drugs.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

None publicly disclosed; focus on partnerships with pharma companies as clients

Beyond the preview

Go deeper on PLAIO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PLAIO.

Explore the full profile